Identification of aberrant splicing events in myelodysplastic syndrome patients with splicing factor gene mutations

Identification of aberrant splicing events in myelodysplastic syndrome patients with splicing factor gene mutations

Bibliographic Details
Main Authors:	Pellagatti, A, Steeples, V, Sharma, E, Repapi, E, Yip, B, Armstrong, R, Dolatshad, H, Lockstone, H, Taylor, S, Giagounidis, A, Vyas, P, Papaemmanuil, E, Woll, P, Killick, S, Malcovati, L, Hellstrom-Lindberg, E, Cazzola, M, Smith, C, Boultwood, J
Format:	Conference item
Published:	Elsevier 2017

Similar Items

The U2AF1S34F mutation induces lineage-specific splicing alterations in myelodysplastic syndromes.
by: Yip, B, et al.
Published: (2017)

The role of splicing factor mutations in the pathogenesis of the myelodysplastic syndromes.
by: Boultwood, J, et al.
Published: (2014)

Impact of spliceosome mutations on RNA splicing in myelodysplasia: dysregulated genes/pathways and clinical associations
by: Pellagatti, A, et al.
Published: (2018)

Splicing factor mutations in the myelodysplastic syndromes: target genes and therapeutic approaches
by: Armstrong, R, et al.
Published: (2017)

Cryptic splicing events in the iron transporter ABCB7 and other key target genes in SF3B1 mutant myelodysplastic syndromes
by: Dolatshad, H, et al.
Published: (2016)

COMPREHENSIVE ANALYSIS OF MUTATION STATUS, GENE EXPRESSION PROFILES, BLOOD AND BONE MARROW COUNTS AND OUTCOME IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES
by: Pellagatti, A, et al.
Published: (2014)

Identification of Prognostic Markers by Gene Expression Profiling In Myelodysplastic Syndrome Hematopoietic Stem Cells
by: Pellagatti, A, et al.
Published: (2010)

Marked down-regulation of nucleophosmin-1 is associated with advanced del(5q) myelodysplastic syndrome.
by: Pellagatti, A, et al.
Published: (2011)

Marked down-regulation of nucleophosmin-1 is associated with advanced del(5q) myelodysplastic syndrome
by: Pellagatti, A, et al.
Published: (2011)

Deregulated Gene Expression Pathways in Myelodysplastic Syndrome Hematopoietic Stem Cells
by: Pellagatti, A, et al.
Published: (2009)

Splicing factor gene mutations in the myelodysplastic syndromes: impact on disease phenotype and therapeutic applications.
by: Pellagatti, A, et al.
Published: (2016)

Identification of Prognostic Markers by Gene Expression Profiling In Myelodysplastic Syndrome Hematopoietic Stem Cells
by: Pellagatti, A, et al.
Published: (2010)

Identification of Prognostic Markers by Gene Expression Profiling In Myelodysplastic Syndrome Hematopoietic Stem Cells
by: Pellagatti, A, et al.
Published: (2010)

Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cells.
by: Pellagatti, A, et al.
Published: (2010)

Gene Expression Profiling of CD34(+) Cells in Patients with Myelodysplastic Syndromes
by: Pellagatti, A, et al.
Published: (2008)

Frequent Mutation of the Polycomb-Associated Gene ASXL1 in the Myelodysplastic Syndromes and in Acute Myeloid Leukaemia
by: Boultwood, J, et al.
Published: (2009)

Marked downregulation of the granulopoiesis regulator LEF1 is associated with disease progression in the myelodysplastic syndromes.
by: Pellagatti, A, et al.
Published: (2009)

Expression profiling of CD34+cells in patients with myelodysplastic syndromes: differences between early and advanced cases and analysis of apoptosis-related genes
by: Pellagatti, A, et al.
Published: (2007)

Identification of gene expression-based prognostic markers in the hematopoietic stem cells of patients with myelodysplastic syndromes.
by: Pellagatti, A, et al.
Published: (2013)

Expression profiling of CD34+cells in patients with myelodysplastic syndromes with and without a del(5q)
by: Pellagatti, A, et al.
Published: (2005)

Frequent mutation of the polycomb-associated gene ASXL1 in the myelodysplastic syndromes and in acute myeloid leukemia.
by: Boultwood, J, et al.
Published: (2010)

Expression profiling of CD34+cells in patients with myelodysplastic syndromes: Involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.
by: Pellagatti, A, et al.
Published: (2006)

Erythroid differentiation enhances RNA mis-splicing in SF3B1-mutant myelodysplastic syndromes with ring sideroblasts
by: Moura, PL, et al.
Published: (2023)

Genome-wide analysis of copy number change and loss of heterozygosity in myelodysplastic syndrome with del(5q) using high-density SNP arrays
by: Wang, L, et al.
Published: (2007)

Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms.
by: Malcovati, L, et al.
Published: (2011)

Cross-kingdom patterns of alternative splicing and splice recognition
by: McGuire, Abigail Manson, et al.
Published: (2010)

Linking aberrant splicing to cardiac aging : unravelling SRPK2
by: Meroshini, M.
Published: (2016)

Haploinsufficiency of RPS14 in 5q- syndrome is associated with deregulation of ribosomal- and translation-related genes (British Journal of Haematology (2008) 142, (57-64))
by: Pellagatti, A, et al.
Published: (2009)

Haploinsufficiency of RPS14 in 5q- syndrome is associated with deregulation of ribosomal- and translation-related genes.
by: Pellagatti, A, et al.
Published: (2008)

Somatic Mutation of SF3B1, a Gene Encoding a Core Component of RNA Splicing Machinery, in Myelodysplasia with Ring Sideroblasts
by: Malcovati, L, et al.
Published: (2011)

Perturbed hematopoietic stem and progenitor cell hierarchy in myelodysplastic syndromes patients with monosomy 7 as the sole cytogenetic abnormality.
by: Dimitriou, M, et al.
Published: (2016)

Gene expression profiles of CD34+ cells in myelodysplastic syndromes: involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.
by: Pellagatti, A, et al.
Published: (2006)

High Throughput Targeted Gene Sequencing in 738 Myelodysplastic Syndromes Patients Reveals Novel Oncogenic Genes, Rare Driver Mutations and Complex Molecular Signatures with Potential Impact for Patient Diagnosis and Prognosis in the Clinic
by: Papaemmanuil, E, et al.
Published: (2012)

Accelerated RNA splicing dynamics during erythroid differentiation amplify mis-splicing in SF3B1-mutant MDS-RS
by: Mead, A, et al.
Published: (2023)

Aberrant splicing of HTT generates the pathogenic exon 1 protein in Huntington disease
by: Sathasivam, Kirupa, et al.
Published: (2013)

Aberrant splicing of HTT generates the pathogenic exon 1 protein in Huntington disease
by: Sathasivam, Kirupa, et al.
Published: (2013)

Gene expression profiling of CD34+ cells in patients with the 5q- syndrome.
by: Boultwood, J, et al.
Published: (2007)

Aberrant splicing and altered spatial expression patterns in fruitless mutants of Drosophila melanogaster.
by: Goodwin, S, et al.
Published: (2000)

L-leucine increases translation of RPS14 and LARP1 in erythroblasts from del(5q) myelodysplastic syndrome patients
by: Bello, E, et al.
Published: (2018)

Recent advances in MDS mutation landscape: splicing and signalling
by: Follo, MY, et al.
Published: (2019)